eess.IVJul 29, 2025

Cyst-X: A Multicenter MRI Benchmark for Pancreatic Cyst Risk Stratification and Cross-Institutional AI

Authors: Hongyi Pan, Gorkem Durak, Halil Ertugrul Aktas, Ziliang Hong, Zhixiang Wang, Elif KelesDeniz Seyithanoglu, Zheyuan Zhang, Alpay Medetalibeyoglu, 

Organizations: Machine & Hybrid Intelligence Lab, Department of Radiology, Northwestern University, Chicago, IL, USA. · Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. · Department of Preventive Medicine, Northwestern University, Chicago, IL, USA. · Division of Gastroenterology and Hepatology, New York University, New York, NY, USA. · 

Abstract

Intraductal papillary mucinous neoplasms (IPMNs) are pancreatic cancer precursors, and guideline-based risk stratification both over-treats indolent lesions and misses progression. We present Cyst-X, a public benchmark of 1,461 T1-weighted (T1W) and T2-weighted (T2W) MRI volumes from 764 patients at seven centers, with expert pancreas masks, risk labels, splits and reference AI risk-prediction models. PanSegNet segmented the pancreas with Dice of 86.34% (T1W) and 89.26% (T2W) on held-out centers. For the primary task, high-risk versus low-risk IPMN, a 3D DenseNet-121 achieved cross-validated AUCs of 74.59% and 73.45%; complementary broad binary and three-class tasks reached 78.67--81.28% and 73.47--75.76%. Because patient images often cannot be pooled across institutions, we also simulated federated learning across the seven centers. On T2W MRI, FedProx was similar to centralized training in center-averaged external AUC (71.00% versus 71.18%) but not in pooled AUC (62.35% versus 77.49%). Radiologist comparisons showed cohort-dependent sensitivity--specificity tradeoffs. Cyst-X supports reproducible method development and identifies within-IPMN risk discrimination and cross-center score comparability as open challenges.

Figures & tables

Appendix figures & tables22 assets

Supplementary material from the paper’s appendix.

Appendix

Explore similar work

Aug 11, 2026

Gaussian Meta-Space Augmentation for Stacking Ensembles in Multimodal IPMN Risk Stratification

Pancreatic cancer is among the most lethal malignancies; risk stratification of intraductal papillary mucinous neoplasms (IPMNs) offers a crucial opportunity for early intervention but typically requires invasive tissue biopsy. Dominant vision-based approaches, including radiomics and deep learning, provide promising but initially separate discrimination opportunities. Similarly, multisequence MRI (T1W/T2W) and anatomically decomposed (head, body and tail) analysis of the pancreas provide additional and potentially complementary signals. Effective fusion of this information is crucial in ordinal IPMN dysplasia risk prediction and can be accomplished via a meticulously regularized and calibrated ensemble stacking combiner. We present cUPMI, a class-conditional Gaussian augmentation of a combiner's log-probability meta-features, and test it on various prediction paradigms. In our multi-center analysis, we find cUPMI adds limited value to properly regularized L2-logistic binary classification stacks, but consistently regularizes higher-capacity tree combiners in the binary and radiomics-only setting (RF +0.015 and XGBoost +0.024 binary AUC, positive in all seeds). Its cleanest ordinal benefit appears for XGBoost on an 8-stream radiomics task (3-class no < low < high, +0.022 QWK in all seeds). Separately, fold-locked fusion of radiomics and 2.5D CNN streams yields the strongest overall model, an RF stack reaching QWK 0.595 (95% CI [0.54, 0.64]) and binary AUC 0.839, surpassing radiomics, 2.5D ResNet, and 3D DenseNet-121 baselines.
Nov 11, 2026

PCLSegNet: Anatomy-Aware Deep Learning Framework for MRI-based Pancreatic Cyst Segmentation and Size Assessment

Early detection and follow-up of pancreatic cystic lesions (PCLs) are crucial, as some of their subtypes, such as mucinous cystic neoplasms (MCNs) and intraductal papillary mucinous neoplasms, carry a significant risk of malignant transformation. Although most AI studies investigating PCLs rely on computed tomography (CT) scans, magnetic resonance imaging (MRI) offers superior soft tissue contrast, making it highly suitable for PCLs assessment. In this work, we propose an anatomy-aware two-stage deep learning framework for automated PCLs segmentation on abdominal MRI scans. First, a publicly available pancreas segmentation model is used to localize the pancreas. Then, we introduce the anatomyaware PCLSegNet, which incorporates anatomical priors as guidance for pancreas and PCLs segmentation. To address the class imbalance problem, we develop a Class-Specific ErrorWeighted (CSEW) loss function. Postprocessing is applied through anatomical constraints.Our proposed method outperforms multi-organ segmentation models such as TotalSegmentator, achieving substantially higher Dice scores for pancreas segmentation. Moreover, it also achieves a superior normalized surface Dice (NSD) and recall for PCLs segmentationcompared to other state-of-the-art models like nnU-Net, while also notably reducing the false negative rate, facilitating the automatic early detection and the noninvasive imaging-based assessment of PCLs.
Oct 29, 2026

Segment Anything Pancreas: A Unified MRI Segmentation Model for Pancreatic Cancer Radiotherapy

Background: Limited tumor annotations and incomplete labels across MRI datasets hinder unified segmentation of pancreatic tumors and organs at risk (OARs) for MRI-guided radiotherapy. Purpose: We propose Pancreas-MedNeXt, a unified model that segments the whole pancreas, its subregions, tumors, and surrounding OARs from one MRI volume. Methods: The model uses a shared MedNeXt encoder-decoder with supervised whole-pancreas and subregion pretraining, followed by multitask fine-tuning. Three output heads predict the pancreatic subregions, tumor, and OARs (stomach, duodenum, kidneys). An annotation-aware loss allows training on partially labeled data without treating unannotated structures as background. Pancreas and tumor were evaluated by three-fold cross-validation on 142 PANTHER patients (92 diagnostic, 50 MR-Linac), subregions and OARs on Cyst-X and AMOS test sets, and pancreas and OARs on 33 external T1-weighted TotalSegmentator scans. Comparisons with nnU-Net, MedNeXt, VISTA3D, and Swin UNETR used the Dice similarity coefficient (DSC) with paired bootstrap 95% CIs. Results: Pancreas-MedNeXt achieved the highest mean pancreas and tumor DSC on diagnostic and MR-Linac MRI. Tumor DSC was 58.41% and 42.55%, exceeding task-specific MedNeXt by 4.94 (95% CI: 0.28-9.45) and 5.89 (95% CI: 2.37-9.72) percentage points, respectively. Whole-pancreas DSC was 85.73% and 70.66%. Pretraining improved head, body, and tail DSC by 2.01, 3.00, and 3.78 percentage points over training from scratch. It also achieved the highest DSC for the pancreas, duodenum, and right kidney on AMOS, and for all five organs on external MRI, exceeding the next-best method by 4.92-8.85 percentage points.Conclusion: A single Pancreas-MedNeXt model segments tumors, pancreatic subregions, and OARs on diagnostic and MR-Linac MRI, which could streamline contouring for pancreatic cancer radiotherapy.